ixlayer Appoints Bernard Esquivel, MD, PhD, as Head of Clinical Innovation

Industry veteran to bolster company’s diagnostic lab services expansion across health plans, retail, providers, biopharma and government

ixlayer, the leading platform for health testing, today announces Bernard Esquivel, MD, PhD, as the Head of Clinical Innovation. Esquivel will play an instrumental role in shaping the company's health testing strategy, including its continued expansion into the labs and diagnostics space.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221214005281/en/

“With demand for more convenient and accessible lab testing growing among health plans, retailers and providers -- so they may better support the patients they serve -- forward-thinking healthcare organizations need an end-to-end platform to power better health testing,” said Pouria Sanae, ixlayer’s Chief Executive Officer and co-founder. “Dr. Esquival’s experience and clinical lens will be critical as we continue to expand our solutions and elevate industry best practices, and we’re thrilled to have him join our team.”

A healthcare industry veteran with more than a decade of experience driving innovations in the healthcare space, Esquivel has deep knowledge and experience in various domains, from genomics and precision medicine to population health management and digital health. His career has been laser focused on making precision medicine and digital health a reality, overcoming challenges to make it clinically actionable and cost-effective.

“The healthcare industry continues to evolve and today’s focus is very much around value-based care driven by population and individual outcomes -- centering the patient and their individual health data more than ever,” said Dr. Esquivel. “This is an exciting time to join the team at ixlayer and I look forward to helping foster innovation and growth in 2023 and beyond.”

ixlayer powers diagnostics and screening programs for organizations including health plans, retail, providers, biopharma and government, that seek more accessible methods for providing preventive care to members and patients. By offering turnkey programs, through a white labeled solution to drive member engagement, ixlayer helps its partners provide high-quality health care that enables members and patients to take control of their health - through early detection, prevention, and condition management.

About ixlayer

ixlayer is redefining next generation patient experiences for lab testing and better health outcomes. We make it easy for people to test outside of clinical settings and take proactive steps towards better health. We partner with payors, retail pharmacies, direct-to-consumer brands, biopharma, health systems, and telehealth providers to create configurable solutions for their patients, all under their own brand. ixlayer’s platform enables patient-friendly digital experiences, 1000s of testing options and seamless integration with our customers and lab partners. ixlayer is the infrastructure for millions of diagnostic tests for partners including the United States Coast Guard, Stanford Health, Salesforce, and multiple national health plans. Learn more at https://ixlayer.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20221214005281/en/